This young #pancreaticcancer patient had a rare ALK fusion - made him eligible for surgery when chemo wasn’t working https://www.pancan.org/stories/survivors/discovery-rare-mutation-gives-survivor-options-hope/ … via @PanCAN
-
-
-
Thanks. That's the kind of story I am looking for.
End of conversation
New conversation -
-
-
Most people won’t benefit from tumor sequencing, and if they do benefit, it is very rarely in the curative sense. We know that; we knew that going into to PMI/All Of Us. Just take a look at the numbers from the non randomized NCI MATCH trial/. They aren’t good!
-
Imagine what the numbers would have been if MATCH were randomized. What’s worse is that the taxpayers spent $30M on MATCH. https://www.biocentury.com/bc-extra/clinical-news/2018-05-16/nci-match-arms-fall-short-asco-abstracts …
@NCIDirectorpic.twitter.com/CpPv4bJeKM
-
They are grasping at straws now. http://ecog-acrin.org/nci-match-eay131-researchers-ctdna-rfp …
#NCIMATCHpic.twitter.com/jN3SW01riy
-
Thanks for this. Quote small numbers of patients generally. I don't expect a miracle, only that one can get lucky if sequencing reveals mutation with known drug available.
-
No problem. Best wishes!
End of conversation
New conversation -
-
-
Two words. Otto Warburg.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
